Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Immunobiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.imbio.2017.10.012PMID 29055565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production

  2016cited by this paper
• Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6*

  2015cited by this paper
• Placental exosomes in normal and complicated pregnancy.

  2015cited by this paper
• First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue

  2015cited by this paper
• Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.

  2015cited by this paper
• B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer.

  2015cited by this paper
• HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity

  2015cited by this paper
• B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

  2015cited by this paper
• Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

  2015cited by this paper
• B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

  2015cited by this paper
• Decidual natural killer cells regulate vessel stability: implications for impaired spiral artery remodelling

  2015cited by this paper
• NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure

  2015cited by this paper
• B7H6-specific chimeric antigen receptors lead to tumor elimination and host anti-tumor immunity

  2015cited by this paper
• Maternal uterine natural killer cells nurture fetal growth: in medio stat virtus.

  2015cited by this paper
• Quantification of the Predominant Immune Cell Populations in Decidua Throughout Human Pregnancy

  2014cited by this paper
• B7-H6 expression in non-small cell lung cancers.

  2014cited by this paper
• Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

  2014cited by this paper
• N-Glycosylation of Asparagine 8 Regulates Surface Expression of Major Histocompatibility Complex Class I Chain-related Protein A (MICA) Alleles Dependent on Threonine 24*

  2014cited by this paper
• Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.

  2013cited by this paper
• B7-H6 Protein Expression has no Prognostic Significance in Human Gastric Carcinoma

  2013cited by this paper
• The role of B7 family molecules in hematologic malignancy.

  2013cited by this paper
• Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.

  2013cited by this paper
• Signaling Pathways in Exosomes Biogenesis, Secretion and Fate

  2013cited by this paper
• Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications

  2013cited by this paper
• NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome

  2013cited by this paper
• Exosomes Secreted by Human Placenta Carry Functional Fas Ligand and TRAIL Molecules and Convey Apoptosis in Activated Immune Cells, Suggesting Exosome-Mediated Immune Privilege of the Fetus

  2013cited by this paper
• B7 family checkpoint regulators in immune regulation and disease.

  2013cited by this paper
• Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands

  2012cited by this paper
• Targeting natural killer cells and natural killer T cells in cancer

  2012cited by this paper
• Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity

  2012cited by this paper
• Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding

  2011cited by this paper
• Trophoblast‐Derived Exosomes Mediate Monocyte Recruitment and Differentiation

  2011cited by this paper
• Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6

  2011cited by this paper
• Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.

  2010cited by this paper
• Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands*

  2010cited by this paper
• REVIEW ARTICLE: B7 Family Molecules as Regulators of the Maternal Immune System in Pregnancy

  2010cited by this paper
• Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function1

  2009cited by this paper
• The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

  2009cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Critical and Differential Roles of NKp46- and NKp30-Activating Receptors Expressed by Uterine NK Cells in Early Pregnancy1

  2008cited by this paper
• Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

  2007cited by this paper
• Decidual NK cells regulate key developmental processes at the human fetal-maternal interface

  2006cited by this paper
• Placenta-Derived Soluble MHC Class I Chain-Related Molecules Down-Regulate NKG2D Receptor on Peripheral Blood Mononuclear Cells during Human Pregnancy: A Possible Novel Immune Escape Mechanism for Fetal Survival1

  2006cited by this paper

• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy.

  2026cites this paper
• Natural killer cell-based therapies in neuroblastoma.

  2024cites this paper
• IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia

  2023cites this paper
• B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma

  2023cites this paper
• B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview

  2022cites this paper
• Extracellular vesicles and immune response during pregnancy: A balancing act *

  2022cites this paper
• B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

  2022cites this paper
• Non‐fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients

  2022cites this paper
• Placental extracellular vesicles in maternal-fetal communication during pregnancy.

  2022cites this paper
• Placenta-Derived Exosomes as a Modulator in Maternal Immune Tolerance During Pregnancy

  2021cites this paper
• [Extracellular vesicles are players of the immune continuum].

  2021cites this paper
• Beyond PD-L1: B7-H6 emerges as a potential immunotherapy target in small cell lung cancer.

  2021cites this paper
• Natural Killer Cells: Tumor Surveillance and Signaling

  2020cites this paper
• Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer

  2020cites this paper
• Escape of tumor cells from the NK cell cytotoxic activity

  2020cites this paper
• Anti-fouling SERS-based immunosensor for point-of-care detection of the B7-H6 tumor biomarker in cervical cancer patient serum.

  2020cites this paper
• Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer

  2020cites this paper
• NKp30 ‐ A prospective target for new cancer immunotherapy strategies

  2020cites this paper
• Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention

  2019cites this paper
• The natural killer cell receptor NKp 30 and its cancer cell ligand B 7 H 6

  2019cites this paper